Fig. 2

Illustration of cost of goods modeling in a biotechnology application. On the top one can see the different parts that compose the cost of goods for manufactured cell products. The bottom part portraits the upstream cost of goods, highlighted in green, as proportional to the overall cost of the treatment. That is a simplification compared to our analysis, which treats costs after cell product arrival at the hospital as independent from the cost of upstream cell processing